APT Neuroscience, Inc. (KOSDAQ:270520)
South Korea
· Delayed Price · Currency is KRW
1,241.00
-26.00 (-2.05%)
Feb 21, 2025, 3:30 PM KST
APT Neuroscience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 |
Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Market Capitalization | 197,059 | 273,753 | 110,948 |
Market Cap Growth | -57.54% | 146.74% | - |
Enterprise Value | 129,697 | 237,291 | - |
Last Close Price | 1241.00 | 2185.00 | 1185.00 |
PS Ratio | 8.78 | 13.41 | 6.32 |
PB Ratio | 2.20 | 4.69 | 2.62 |
P/TBV Ratio | 2.09 | 4.89 | 2.74 |
P/FCF Ratio | - | - | 132.07 |
P/OCF Ratio | - | - | 96.32 |
EV/Sales Ratio | 6.61 | 11.62 | - |
Debt / Equity Ratio | 0.23 | 0.51 | 0.38 |
Debt / FCF Ratio | - | - | 19.02 |
Asset Turnover | 0.16 | 0.25 | - |
Quick Ratio | 3.34 | 1.79 | 2.24 |
Current Ratio | 3.53 | 1.87 | 2.49 |
Return on Equity (ROE) | -19.48% | -9.93% | - |
Return on Assets (ROA) | -3.58% | -5.12% | - |
Return on Capital (ROIC) | -3.88% | -5.75% | - |
Earnings Yield | -8.13% | -1.83% | -2.93% |
FCF Yield | -2.15% | -3.18% | 0.76% |
Buyback Yield / Dilution | 25.36% | -65.51% | - |
Total Shareholder Return | 25.36% | -65.51% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.